key: cord-0782466-3epueoyi
authors: Xia, Bingqing; Shen, Xurui; He, Yang; Pan, Xiaoyan; Wang, Yi; Yang, Feipu; Fang, Sui; Wu, Yan; Zuo, Xiaoli; Xie, Zhuqing; Jiang, Xiangrui; Chi, Hao; Meng, Qian; Zhou, Hu; Zhou, Yubo; Cheng, Xi; Chen, Tong; Xin, Xiaoming; Jiang, Hualiang; Xiao, Gengfu; Zhao, Qiang; Zhang, Lei-Ke; Shen, Jingshan; Li, Jia; Gao, Zhaobing
title: SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damage and constitutes an antiviral target
date: 2020-06-29
journal: bioRxiv
DOI: 10.1101/2020.06.27.174953
sha: 0cb80b4d052d23af8f9223efd58894505fa5a48b
doc_id: 782466
cord_uid: 3epueoyi

Cytokine storm and multi-organ failure are the main causes of SARS-CoV-2-related death. However, the origin of the virus’ excessively damaging abilities remains unknown. Here we show that the SARS-CoV-2 envelope (2-E) protein alone is sufficient to cause acute respiratory distress syndrome (ARDS)-like damage in vitro and in vivo. Overexpression of 2-E protein induced rapid pyroptosis-like cell death in various susceptible cells and robust secretion of cytokines and chemokines in macrophages. Intravenous administration of purified 2-E protein into mice caused ARDS-like pathological damage in lung and spleen. Overexpressed 2-E protein formed cation channels in host cell membranes, eventually leading to membrane rupture. Newly identified channel inhibitors exhibited potent anti-SARS-CoV-2 activity and excellent protective effects against the 2-E-induced damage both in vitro and in vivo. Importantly, their channel inhibition, cell protection and antiviral activities were positively correlated with each other, supporting 2-E is a promising drug target against SARS-CoV-2.

damage-associated molecular patterns (DAMPs), including ATP and DNA (Merad and Martin, 2020; Tay et al., 2020) . It is also very likely that SARS-CoV-2 may antagonize interferon responses in various interferon signaling pathways according to studies on SARS-CoV (Blanco-Melo et al., 2020; Merad and Martin, 2020; Tay et al., 2020) .

However, in addition to the dysfunctional defensive responses of host cells and the antagonism of the interferon signaling pathway by the virus, whether the SARS-CoV-2 itself possesses an offensive virulence factor that can induce cytokine storm and kills targeted cells in a direct and rapid manner remains unknown.

The SARS-CoV-2 envelope (2-E) protein is the smallest major structural protein but has been largely neglected, in contrast to other major structural proteins such as the spike (S) protein (Wrapp and Wang, 2020) . Knowledge on envelope (E) protein has been limited from a few studies on the highly conserved E protein of SARS-CoV that emerged in 2003 (Zhong et al., 2003 . Expression of the E protein during virus replication was thought to be essential for SARS-CoV assembly and budding (Westerbeck and Machamer, 2019) . A recent study argued that the SARS-CoV-E protein does not participate in virus production but is an independent virulence factor (Nieto-Torres et al., 2014) . To date, however, no study on the 2-E protein has been reported and there is no effective drug targeting the 2-E protein. Here, we showed that the 2-E protein forms a cation channel that is lethal to host cells and inhibition of the 2-E channel is new antiviral strategy.

The influences of 2-E on host cells were evaluated in 14 cell lines and the survival rate of each cell line were measured at 12, 24, 48 and 72 h after transient transfection of SARS-CoV-2-E plasmids ( Figure 1A ). Among them, Vero E6 (African green monkey kidney), 16HBE (human bronchial epithelium), A549 (human alveolar basal epithelium), HeLa (human cervical cancer) and Caco2 (human intestinal carcinoma) cells gradually died while the rest remained in a healthy state. Additionally, a conserved proline-centred β-coil-β motif mutant (SARS-CoV-2-E-4a) plasmid was also tested; this mutant allows more SARS-CoV-E protein transfer to the plasma membrane from the Golgi (Cohen et al., 2011) . A relatively high expression level of 2-E was observed in the susceptible cell lines, while the rest of the cell lines displayed no expression ( Figure 1A , Figure S1 ). The 4a mutant not only improved the 2-E expression level but also caused more severe cell death ( Figure S1 ). Interestingly, all susceptible cells coincided with the vulnerable organs observed clinically in patients with SARS-CoV-2 infections (C. et al., 2020; Wu et al., 2020) . 16HBE and Vero E6 cells were selected for further examination, and the latter was transfected with a GFP-tagged plasmid to indicate the expression of 2-E. Imaging assays and video showed that the dying cells exhibited characteristic large bubbles, similar to pyroptotic bodies from the plasma membrane, which resembled the morphological changes in Vero E6 cells infected by SARS-CoV-2 ( Figure 1B and C and Video S1). Plasma membrane separation revealed that 2-E protein was translocated to membranes after expression ( Figure 1D ). Flow cytometry showed that the cells expressing 2-E proceeded to the Annexin V and propidium iodide double-positive stage ( Figure 1E ). The double-positive results represent phospha-tidylserine (PS) exposure and loss of plasma membrane integrity, which are hallmarks of pyroptosis or necrosis (Gong et al., 2017; Wang et al., 2017) .

Among the tested biomarkers for apoptosis, necroptosis and pyroptosis, however, levels of neither phosphorylated mixed lineage kinase domain-like protein (p-MLKL, necroptosis) nor cleaved gasdermin D (GSDMD, pyroptosis) were increased ( Figure   1F , Figure S2 ). These data suggest that 2-E induce pyroptosis-like cell death perhaps in an atypical manner.

Previous studies have shown that the SARS-CoV-E protein is associated with macrophage infiltration and inflammatory cytokine production (Nieto-Torres et al., 2014; Nieto-Torres et al., 2015) . Three methods were used to explore the 2-E induced pathological processes in macrophages ( Figure 2A ). First, we transfected a mouse macrophage cell line (RAW 264.7) with SARS-CoV-2-E plasmids for 24 and 48 h. As shown in Figure 2B and Figure S3 , TNF- and IL-6 levels in cells and supernatants were significantly upregulated after transfection, as previously reported in COVID-19 patients (Merad and Martin, 2020) . Second, we treated macrophages with purified 2-E protein and obtained similar enhanced cytokine levels ( Figure 2C ). Given that virus infection is related to innate and adaptive immune responses, it is logical to speculate that host cell damage by 2-E would lead to a secondary inflammatory cascade. To test this hypothesis, we transfected Vero E6 with 2-E plasmids, and 24 h later, the culture supernatant was collected and was used to treat RAW264.7 cells. As expected, the supernatant of impaired cells promoted cytokine expression as well, including that of IL-1RA, IL-1 and CCL5, some key markers reported for cytokine storm ( Figure 2D ).

These data indicate that 2-E itself is sufficient to promote inflammatory responses in macrophages.

To explore the potential influences of 2-E protein in vivo, purified 2-E protein was injected intravenously for 2, 6, and 72 h in C57BL/6 mice ( Figure 3A -C, Figure S4) . Surprisingly, we observed severe foci of pulmonary consolidation in the lung and spleen edema at 72 h ( Figure 3D ), but not found in mock and bovine serum albumin (BSA) groups ( Figure S5 ). H&E staining of lung tissue showed marked inflammatory cell infiltration, edema, pulmonary interstitial hyperemia, hemorrhage, and alveolar collapse. The observed animal phenotype was consistent with COVID-19 patients' lungs, in which the first and most severe lesion signs appeared (Zhang et al., 2020) . In addition, SARS-CoV-2 infection may trigger an overwhelming inflammatory response, which leads to injuries to multiple organs (Bao et al., 2020; Noris et al., 2020; Tay et al., 2020) . We used qRT-PCR and ELISA to characterize the pathological features. As illustrated in Figure 3E and F, the expression of cytokines (IL-1RA, IL-1, IL-6, TNF-, etc.) and chemokines (CCL2,3, and 5, CXCL9, etc.) increased dramatically in vivo, along with the notably upregulated inflammatory markers, which also correlate with the previously reported cytokine storm in patients ( Figure 3E and F). Our data suggest that 2-E protein alone is sufficient to drive pulmonary congestion and inflammation.

 SARS-CoV-2-E forms cation channels.

It has been reported that the executer of pyroptosis (GSDMD) and necroptosis (p-MLKL) destroy the membrane integrity by either forming pores or channels (Ding et al., 2016; Xia et al., 2016) . In addition, the E protein of SARS-CoV was found to be able to form pores with ion channel activity (Liao et al., 2006; Pervushin et al., 2009; Verdiá-Báguena et al., 2013) . A planar lipid bilayer recording technique was used to assess potential electric signals mediated by 2-E. Typical single-channel currents were captured when the protein was reconstituted in asymmetric 50:500 mM KCl solutions and 3:2 PC/PS lipid membranes at applied potentials of -100 mV to +100 mV ( Figure   4A ). The measured reversal potential (59.25 mV) was very close to the theoretical equilibrium potential of K + , indicating that the 2-E channels were permeable to K + but not to Cl -. By examining the reversal potentials in solutions containing varied concentrations of K + , Na + and Cl -, we found the 2-E channels were also permeable to Na + in the presence of K + and Cl -( Figure 4A and B). In addition, 2-E channels exhibited a much lower permeability to divalent Ca 2+ and Mg 2+ in the presence of K + (Figure 4 A and E). The permeability rank ((PNa + ≈PK + )／(PCa 2+ ≈PMg 2+ )≈3.0) suggested that 2-E channel possesses a distinct selectivity pattern from classic voltage dependent channels. The pH value on the lumen side of organelles may change after coronavirus infection (Westerbeck and Machamer, 2019). We found that both the amplitude and voltage dependence of 2-E channel-mediated currents gradually increased when pH decreased. At pH 10, the 2-E channel almost completely closed ( Figure 4C and D).

Collectively, our data support that 2-E forms a type of pH sensitive cation channel.

We sought to identify inhibitors for 2-E channels using the planar lipid bilayer recording technique. Tetraethylammonium (TEA, 5 mM), Tetrodotoxin (TTX, 100 M) and Nifedipine (100 M), three classic inhibitors of potassium, sodium and calcium channels, respectively, showed negligible effects on 2-E channels. Although 5-(N,Nhexamethylene)-amiloride (HMA) and amantadine, two reported inhibitors of proton pumps and SARS-CoV-E channels, exhibited inhibitory activity on 2-E channels at 50 M or greater, further investigation into these compounds was hindered by their strong cytotoxicity. BE12 (Berbamine), a type of bisbenzylisoquinoline alkaloid isolated from Berberis, drew our attention after screening an in-house compound collection.

Although BE12 was a weak inhibitor of 2-E channels, with an IC50 of 111.50 M, it exhibited minor cytotoxicity, which allowed us to further test its cell protection activity against 2-E induced cell death and anti-SARS-CoV-2 activity using Vero E6 cells.

Encouraged by the promising cell protection and antiviral activity of BE12, four more channel inhibitors (BE30~33) were designed, synthesized and evaluated individually.

Among them, BE33 exhibited exceptional antiviral activity against SARS-CoV-2 infection, with an IC50 of 0.94 M and negligible cytotoxicity ( Figure 5A -D). In addition, we treated the 2-E injected mice with BE-33 and found that BE-33 (0.50 mg/Kg) significantly reduced cytokine secretion ( Figure 5E ). In addition, it is noteworthy that the channel inhibition activity, the cell protection activity against 2-Einduced cell death and the antiviral activity of this class of compounds are positively correlated with each other ( Figure 5F ), indicating the importance of the channel activity of 2-E.

The lack of efficient antiviral drugs for SARS-CoV-2 has prompted the urgent need for developing new therapeutic development for COVID-19. A better understanding of which viral proteins are major risk factors for organ and immune system damage is crucial to develop rationale-based clinical therapeutic strategies. Our study supports that the 2-E channel acts as an "offensive" virulence factor carried by SARS-CoV-2, leading to the robust inflammatory responses and rapid cell death. 2-E channels may act either by themselves or via other proteins to increase ion fluxes across the membranes, which changes the ion homeostasis and eventually results in membrane rupture (Feltham and Vince, 2018) . In contrast to exocytosis, a common and mild mechanism for virus release, a large amount of SARS-CoV-2, 2-E and other DAMPs can be released simultaneously because of the sudden cell death induced by 2-E channels. Coincidently, COVID-19 patients' lungs showed evident desquamation of pneumocytes and hyaline membrane formation, some COVID-19 patients may worsen rapidly to sudden stroke from mild symptoms.

It has been demonstrated that depletion of intracellular potassium will promote robust secretion of cytokines and aggravate the MLKL channel-mediated necroptosis and GSDMD pore-mediated pyroptosis (Conos et al., 2017; Ding et al., 2016) . The disease severity of COVID-19 patients is linked to electrolyte imbalance, including reduced serum concentrations of potassium, sodium and calcium (Banerjee et al., 2018; Lippi and South, 2020) . Identification of 2-E as a new type of potassium permeable channels may therefore unravel the pathogenic mechanisms underlying hypokalaemia exacerbating ARDS, which is a common complication in COVID-19 patients (Louhaichi et al., 2020) . In addition to 2-E channels, multiple proteins exhibiting channel activity have been also identified in other highly pathogenic respiratory viruses, including SARS-CoV, MERS-CoV, and Influenza A (Cady et al., 2010; Nieto-Torres et al., 2014; Surya et al., 2015) . Although how these channels modulate the ion homeostasis across the virus membrane remains unclear, it is generally believed that these channels are necessary for the virus production and maturation (Castano-Rodriguez et al., 2018) . The requirement of the channels in a large number of pathogenhost interactions makes the virus channel research a field of growing interest.

One limitation of our study is the lack of evidence in the context of SARS-CoV-2 infection in vivo, which can technically be achieved by generating of SARS-CoV-2 without 2-E using reverse genetics. However, the 2-E deleted SARS-CoV-2 may replicate more effectively and thus this experiment was not conducted. Although the in vivo antiviral activity of the newly identified channel inhibitors needs further studies, their potent antiviral activity in vitro and excellent protection effects against ARDSlike damage in vivo shed light on the drug development of 2-E channel inhibitors. Given that 2-E can function as ion channels in the viral membranes, similar to how they function in host cells, we propose that 2-E channels may represent a new class of dualfunction targets against SARS-CoV-2.

We thank Prof. Eric Xu for linguistic assistance during the preparation of this All data are representative of three independent experiments.

Wild type and mutant ( For cytotoxicity assay, Vero E6 cells were seeded in 96-well plates with 15,000 cells per well overnight. Compounds were diluted with medium to appropriate concentrations, a volume of 100 μL was added to each well and then incubated for 24 h.

Cell viability and Cytotoxicity were measured using the CCK8 kit (40203ES60, Yishen, China). Assays were performed according to the manufacturer's instructions. Measure the absorbance at 450 nm with Thermo Scientific Microplate Reader (Thermo Fisher Scientific Inc., USA).

Inc., USA) was used to extract cytosolic and membrane proteins. Briefly, cells were washed with ice-cold PBS before the cells were harvested and permeabilized in a Permeabilization Buffer. Cytosolic and crude membrane fractions were separated by centrifugation at 3,00 × g for 5 mins. The supernatants were taken as cytosolic proteins.

The pellets were washed with PBS and then solubilized to collect membrane proteins. 

Total RNAs were extracted from cells and tissues using Trizol (Invitrogen, USA) and all total Nucleic Acid Isolation Kit (Ambion Inc., USA), following the manufacturer's instruction. The experiment was performed at least three times using SYBR Premix Ex The single-channel conductance and open time were determined by fitting to Gaussian functions or to single or bi-exponential equations. Opening times less than 0.5 -1.5 ms were ignored. The equilibrium potential was calculated using the Nernst equation and

Goldman-Hodgkin-Katz flux equation as reported (33).

SARS-CoV-2 (nCoV-2019BetaCoV/Wuhan/WIV04/2019) was preserved at Wuhan institute of virology, Chinese Academy of Sciences. It was propagated and titrated with Vero E6 cells, and its associated operations were performed in a biosafety level 3 (BSL-3) facility. For viral inhibition assay, Vero E6 cells seeded in 48-well plate with 50000 cells per well overnight were firstly pre-treated with gradient-diluted compounds for 1 h, followed by adding SARS-CoV-2 (MOI = 0.01) and incubating for 1 h at 37°C. After that, the virus-drug mixture was completely removed, and the cells were washed twice with PBS followed by adding fresh medium with compounds. 24 h later, viral RNA was extracted from cell supernatants with Mini BEST Viral RNA/DNA Extraction Kit (Takara, Japan) according to the instructions, then reversely transcribed with Prime ScriptTM RT reagent Kit with gDNA Eraser (Takara, Japan). Viral genome copies were quantified with Takara TB Green® Premix Ex Taq™ II (Takara, Japan) by a standard curve method on ABI 7500 using a pair of primers targeting S gene. The forward primer (5'-3'): GCTCCCTCTCATCAGTTCCA; the reverse primer (5'-3'):

CTCAAGTGTCTGTGGATCACG.

Inhibitor synthesis General procedure. Reagents and solvents were purchased from commercial sources and used without purification. HSGF 254 (0.15−0.2 mm thickness) was used for analytical thin-layer chromatography (TLC). All products were characterized by their NMR and MS spectra. 1 H NMR spectra was recorded on a Bruker spectrometer with TMS as the internal standard. Chemical shifts were given in δ values (ppm) and

coupling constants (J) were given in Hz. Signal multiplicities were characterized as s (singlet), d (doublet), t (triplet), m (multiplet) and br (broad). The mass spectra were determined on a Thermo-Fisher Finnigan LTQ mass spectrometer. HPLC spectra were recorded by an Agilent 1100 (Agilent Corporation) with SunFire C18 (150 × 4.6 mm, 5 μm) with two solvent systems (acetonitrile/0.02 M 1-octanesulfonic acid sodium in water). Purity was determined by reversed-phase HPLC and was ≥ 95% for BE30, BE31, BE32 and BE33.

Scheme S1: Synthetic route of compounds BE30 and BE31 a Video S1

16HBE cells were recorded 7 h after transfected with 2-E-GFP for the duration of time indicated on the left corner (h : min : s: ms). Scale bar, 25 μm. Also see Figure 1 . A. Gross pathology and histopathology of lung and spleen from control mice (Trisbuffered saline, TBS; Bovine serum albumin, BSA, (25 g/g body weight)), and model mice (2-E proteins) . B. qRT-PCR analysis of the lung and spleen tissues after injection of TBS, BSA and 2-E proteins.

To a 10 mL round-bottom flask was added phenol BE12 (185 mg, 0.271 mmol), DCM (2 mL), DMAP (16.6 mg, 0.136 mmol, 0.5 eq) and triethylamine (0.189 mL

2 eq) was added dropwise over 2 mins. The reaction was slowly warmed to room temperature. After 30 mins, the reaction was diluted with DCM (5 mL) and quenched with 0.5 M aqueous HCl (1.1 mL). The organic layer was separated and washed with sat. aq. NaHCO3 (5 mL), then brine (5 mL), dried over Na2SO4, filtered, and concentrated via rotary evaporation. The crude product was purified by silica gel chromatography (DCM:MeOH = 80:1) to give triflate BE12-1 as a light-yellow solid (160 mg, 0.217 mmol, 80% yield). 1 H NMR (500 MHz, Chloroform-d) δ 7.47 (dd

A mixture of triflate BE12-1 (170 mg, 0.230 mmol), Zn(CN)2 (40 mg, 0.345 mmol

mg, 0.03 mmol, 0.13 eq) in DMAC (2 mL) in a 10 mL round-bottom flask was purged with nitrogen for three times at room temperature. Then the mixture was heated to 150 °C and stirred at this temperature for 3 h. After cooling to room temperature, ethyl acetate (10 mL) was added and the resulting mixture was filtered. The filtrate was washed with water (2 × 5 mL), brine (5 mL), dried over Na2SO4, filtered, and concentrated via rotary evaporation. The crude product was purified by silica gel chromatography

Chloroform-d) δ 7.49 (dd, J = 8.4, 2.3 Hz, 1H), 7.39 (d, J = 7.9 Hz, 1H)

To a solution of free base of BE30 (105 mg) in methanol (1 mL) was added concentrated hydrochloric acid (14.9 µL). The resulting solution was stirred at room temperature for 5 min and then concentrated via rotary evaporation. Methyl tert-butyl ether (1 mL) was added to the residue and the precipitation was filtered and dried under vacuum at 45 °C to provide hydrochloride salt of BE30 as a yellow solid (90 mg)

115 mmol) and Raney nickel (100 mg) was suspended in formic acid (3 mL) and water (0.1 mL) and heated to 90 °C for 2 h. The mixture was then filtered, rinsed with methanol, and concentrated. To the resulting residue was added DCM (5 mL) followed by sat. aq. NaHCO3 until basic. The organic layer was separated, dried over Na2SO4, and concentrated. The crude product was purified by silica gel chromatography (DCM:MeOH = 75:1) to give aldehyde BE12-2 as a light-yellow oil

After 2 h, the reaction was quenched with sat. aq. NH4Cl (1 mL) and extracted with DCM (2 × 2 mL). The combined organic layer was washed with brine (2 mL), dried over Na2SO4, filtered, and concentrated via rotary evaporation. The crude product was purified by silica gel chromatography (DCM:MeOH = 65:1) to give free base of BE31 as a light-yellow solid (20 mg, 0.032 mmol, 55% yield). Two sets of 1 H NMR data representing two rotamers (~3:2) were observed as indicative of the presence of atropisomers in bisbenzylisoquinoline type alkaloids involving planar chirality. 1 H NMR (600 MHz

Hz, 1H), 7.21 (d, J = 7.3 Hz, 1H), 6.92 (m, 2H)

minor rotamer) δ 7.47 (d, J = 7.8 Hz, 1H), 7.43 (brs, 1H), 7.16 (brs, 1H), 6.92 (m, 2H)

To a solution of free base of BE31 (16 solution was stirred at room temperature for 5 mins and then concentrated via rotary evaporation. Acetonitrile (0.5 mL) was added to the residue and the precipitation was filtered and dried under vacuum at 45 °C to provide hydrochloride salt of BE31 as an off-white solid (13 mg)

Synthetic route of compound BE32 a a Reagents and conditions: EDCI, DMAP, DCM, rt. Synthesis of BE32

2 eq) were added to a suspension of phenol BE12 (100 mg, 0.147 mmol) and L-thioctic acid (31 mg, 0.150 mmol, 1.0 eq) in DCM (3 mL) at room temperature. The mixture was stirred for 5 h before water (2 mL) was added. The organic layer was separated, washed with brine (2 mL), dried over Na2SO4, filtered, and concentrated. The crude product was purified by silica gel chromatography (DCM:MeOH = 50:1) to give BE32 as a light-yellow solid (63 mg, 0.079 mmol, 54% yield). Two sets of 1 H NMR data representing two rotamers

74 (s, 1H), 6.51 (s, 1H × 2), 6.34 (dd, J = 8.2, 2.6 Hz, 1H)

69 (s, 1H), 6.55 (s, 1H), 6.54 (s, 1H), 6.37 (m, 1H)

Two sets of 1 H NMR data representing two rotamers (~7:3) were observed. 1 H NMR (500 MHz, Methanol-d4, major rotamer) δ 7.45 (dd, J = 8.4, 2.3 Hz, 1H), 7.13 (m, 1H), 6.98 (dd, J = 7.9, 2.1 Hz, 1H), 6.94 (d, J = 8.1 Hz, 1H), 6.89 (m, 1H), 6.76 (s, 1H), 6.53 (s, 1H), 6.52 (s, 1H), 6.37 (dd, J = 8.2, 2.6 Hz, 1H), 5.53 (d, J = 1.9 Hz, 1H), 4.34 (d, J = 5.9 Hz, 1H), 3.92 (m, 1H), 3.80 (s, 3H), 3.64 (s, 3H

Magnesium protects against sepsis by blocking gasdermin D Nterminal-induced pyroptosis